A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.

@article{Byrne2009APD,
  title={A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stents.},
  author={Robert A. Byrne and Julinda Mehilli and Raisuke Iijima and Stefanie R Schulz and J{\"u}rgen Pache and Melchior Seyfarth and Albert Schoemig and Adnan Kastrati},
  journal={European heart journal},
  year={2009},
  volume={30 8},
  pages={923-31}
}
AIMS Long-term polymer residue in the coronary milieu is a consequence of current drug-eluting stent (DES) therapy and has been implicated in late adverse events. We developed a novel polymer-free rapamycin- and probucol-eluting stent (Dual-DES) and compared its efficacy against commercially available permanent polymer-based sirolimus-eluting (SES; Cypher) and zotarolimus-eluting (ZES; Endeavor) stents. METHODS AND RESULTS Between March 2006 and July 2007, a total of 1007 patients undergoing… CONTINUE READING
52 Citations
43 References
Similar Papers

Citations

Publications citing this paper.
Showing 1-10 of 52 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 43 references

Duration of antiplatelet therapy following intracoronary stenting: are changes needed

  • RA Byrne, A. Kastrati
  • Eur Heart J Suppl 2008;10:I25–I29
  • 2008
1 Excerpt

Similar Papers

Loading similar papers…